Tilray Brands, Inc. Common Stock (TLRY) is a publicly traded Healthcare sector company. As of May 21, 2026, TLRY trades at $5.39 with a market cap of $619.55M and a P/E ratio of 0.72. TLRY moved +3.93% today. Year to date, TLRY is -43.02%; over the trailing twelve months it is +19.45%. Its 52-week range spans $3.51 to $23.20. Analyst consensus is buy with an average price target of $7.98. Rallies surfaces TLRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes TLRY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $5.39 |
| Market Cap | $619.55M |
| P/E Ratio | 0.72 |
| EPS | $7.51 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.20 |
| 52-Week Low | $3.51 |
| Volume | 2.52M |
| Avg Volume | 0 |
| Revenue (TTM) | $858.27M |
| Net Income | $-1.34B |
| Gross Margin | 27.68% |
6 analysts cover TLRY: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.98.